tretazicar has been researched along with apaziquone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phillips, RM; Seville, S; Shnyder, SD; Wright, CW | 1 |
| Sugget, N; Walton, MI; Workman, P | 1 |
| Riley, RJ; Workman, P | 1 |
| Chen, S; Deng, PS; Ebenstein, D; Friedlos, F; Fung, M; Knox, R; Lewis, AD; Tsai, TM; Workman, P; Wu, K | 1 |
| Melo, T; Misra, V; Rauth, AM | 1 |
| Celli, CM; Jaiswal, AK; Knox, R; Tran, N | 1 |
| Boyle, RG; Travers, S | 1 |
2 review(s) available for tretazicar and apaziquone
| Article | Year |
|---|---|
DT-diaphorase and cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Aziridines; Benzoquinones; Dihydrolipoamide Dehydrogenase; Drug Design; Enzyme Induction; Gene Expression Regulation, Enzymologic; Humans; Indolequinones; Indoles; Mitomycin; Neoplasms; Precancerous Conditions; Tirapazamine; Triazines | 1992 |
Hypoxia: targeting the tumour.
Topics: Anthraquinones; Antineoplastic Agents; Aziridines; Benzoquinones; Cell Hypoxia; Clinical Trials, Phase III as Topic; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indolequinones; Neoplasms; Prodrugs; Quinolines; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 2006 |
5 other study(ies) available for tretazicar and apaziquone
| Article | Year |
|---|---|
Synthesis of cryptolepine analogues as potential bioreducible anticancer agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cytosol; Drug Screening Assays, Antitumor; Humans; Indole Alkaloids; Inhibitory Concentration 50; Prodrugs; Quinolines; Quinone Reductases; Structure-Activity Relationship | 2007 |
The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins.
Topics: Animals; Antineoplastic Agents; Aziridines; Carcinoma 256, Walker; Cell Hypoxia; Colonic Neoplasms; Humans; In Vitro Techniques; Indolequinones; Indoles; Mitomycin; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Prodrugs; Rats; Tirapazamine; Triazines | 1992 |
Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Topics: Amino Acid Sequence; Animals; Aziridines; Base Sequence; DNA Damage; DNA Primers; Escherichia coli; Humans; In Vitro Techniques; Indolequinones; Indoles; Kinetics; Mice; Molecular Sequence Data; NAD(P)H Dehydrogenase (Quinone); Prodrugs; Rats; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Species Specificity | 1995 |
Bioreductive therapies: an overview of drugs and their mechanisms of action.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; DNA, Neoplasm; Forecasting; Humans; Indolequinones; Indoles; Misonidazole; Mitomycin; Nitrofurans; Nitroimidazoles; Oxidation-Reduction; Prodrugs; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1998 |
NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Topics: Animals; Antineoplastic Agents; Aziridines; Benzopyrenes; Biotransformation; Cell Survival; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Cross-Linking Reagents; DNA, Complementary; Dose-Response Relationship, Drug; Hydroquinones; Indolequinones; Keratinocytes; Mice; Mice, Knockout; Mitomycin; Mitomycins; Quinone Reductases; Quinones; Transfection; Vitamin K 3 | 2006 |